Giampaolo Merlini, MD Researcher
IRCCS Policlinico San Matteo Hospital
University of Pavia
Viale Golgi 19
Dr. Giampaolo Merlini is the Director of the Center for Research and Treatment of Systemic Amyloidosis, and of the Biotechnology Research Laboratories, Scientific Institute Policlinico San Matteo, University of Pavia, Italy. He is Professor of Clinical Biochemistry at the University of Pavia and the President of the Post-Graduate Course in Medical Biotechnology. He is also the President of the International Society of Amyloidosis and Chairman of the Committee on Plasma Proteins, International Federation of Clinical Chemistry and Laboratory Medicine.
He attended the Medical School of the University of Pavia as an alumnus of the Ghislieri College. After being awarded his medical degree, he trained in clinical and laboratory investigation of monoclonal gammapathies at Malmö General Hospital, Lund University, Sweden.
Dr. Merlini’s main research interests are the pathogenesis, natural history, diagnosis and treatment of monoclonal gammapathies, in particular immunoglobulin light chain amyloidosis. Recently his research has focused on the investigation of biomarkers for assessing prognosis and response to therapy and on the development of novel therapeutic agents and treatment designed in the light of advances in the understanding of the molecular mechanisms of these diseases.